SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-144922
Filing Date
2021-04-30
Accepted
2021-04-30 15:59:59
Documents
14
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d107927ddef14a.htm DEF 14A 1043831
2 GRAPHIC g107927g01a50.jpg GRAPHIC 170608
3 GRAPHIC g107927g41p15.jpg GRAPHIC 20836
4 GRAPHIC g107927g44q12.jpg GRAPHIC 29033
5 GRAPHIC g107927g63s72.jpg GRAPHIC 55233
6 GRAPHIC g107927g75q32.jpg GRAPHIC 30379
7 GRAPHIC g107927g85o50.jpg GRAPHIC 46642
8 GRAPHIC g107927g89a01.jpg GRAPHIC 5317
9 GRAPHIC g107927g89b02.jpg GRAPHIC 2047
10 GRAPHIC g107927g89c03.jpg GRAPHIC 1571
11 GRAPHIC g107927g89d04.jpg GRAPHIC 2250
12 GRAPHIC g107927g89e05.jpg GRAPHIC 2566
13 GRAPHIC g107927g90a90.jpg GRAPHIC 1914
14 GRAPHIC g107927g97q10.jpg GRAPHIC 62768
  Complete submission text file 0001193125-21-144922.txt   1622192
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33277 | Film No.: 21877611
SIC: 2834 Pharmaceutical Preparations